Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 11.84
+0.14 (1.20%)
Sep 2, 2026, 1:19 PM CST
Guanhao Biotech Market Cap
Guanhao Biotech has a market cap or net worth of 3.1 billion as of September 1, 2026. Its market cap has decreased by -30.36% in one year.
Market Cap
3.10B
Enterprise Value
3.00B
Revenue
361.40M
Ranking
n/a
PE Ratio
187.53
Stock Price
11.84
ChartMarket Cap Chart
Since July 6, 2011, Guanhao Biotech's market cap has increased from 2.74B to 3.10B, an increase of 13.06%. That is a compound annual growth rate of 0.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.10B | -15.52% |
| Dec 31, 2025 | 3.67B | 15.03% |
| Dec 31, 2024 | 3.19B | -11.21% |
| Dec 29, 2023 | 3.60B | 31.91% |
| Dec 30, 2022 | 2.73B | -44.52% |
| Dec 31, 2021 | 4.91B | -26.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 3.53B |
| Jiangsu Bioperfectus Technologies | 3.52B |
| Lifecome Biochemistry | 3.41B |
| Shanghai Shen Lian Biomedical | 3.36B |
| Hinova Pharmaceuticals | 3.35B |
| Qingdao Vland Biotech INC. | 3.25B |
| Baolingbao Biology | 3.11B |
| Beijing Kawin Technology Share-Holding | 3.06B |